top of page
ChatGPT Image Jul 12, 2026, 05_49_04 PM.png

A new era of 
reproductive medicine

Applying modern discovery tools to the development of new reproductive therapies, starting with IVF. 

IVF works, but it's hard on patients.

​We're here to change that.

We mature eggs outside the body, so patients can skip the hormones. 

Today's IVF requires weeks of hormone injections that cause physical side effects, disrupt daily life, and add emotional burden. For many women with hormone-sensitive conditions, IVF isn't an option at all.

COCsExtracted_edited.jpg
Picture for Wix.png

Vitra systems supports egg maturation outside of the body in a controlled environment, elliminating intensive hormone stimulation during fertility treatments.

In Vitro Fertilization by the Numbers

1 in 6

People globally affected by infertility

10M+

Women in the U.S. need IVF

<500K

Cycles in the U.S

300M

Predicted IVF births this century

Infertility is on the rise. Yet less than 5% of women who need IVF can access it.

MISSION

To make fertility care safer, simpler, and more accessible.

Vitra is a women-led biotech company reimagining fertility care to be more adaptable to individual patient needs. Our technologies aim to give patients and clinicians greater control over treatment by:
 

Reducing Hormone Burden 

Fewer injections, fewer side effects, shorter cycles for patients

 

Improving Efficacy

Superior blastocyst formation and embryo quality in preclinical models

 

Enabling Clinical Adoption

Our technology is designed to fit into existing IVF workflows

vitra_labs_logo_edited_edited_edited_edited_edited_edited.png

Vitra Labs, Inc. technology is in preclinical development and not yet FDA-approved. Vitra's platform is investigational and not available for clinical use. Timing and regulatory classification are anticipated and subject to change. Information on this site is for research and educational purposes only.

© 2025 Vitra Labs, Inc.

  • LinkedIn
bottom of page